Cytophage Technologies Ltd. (TSXV:CYTO)

Canada flag Canada · Delayed Price · Currency is CAD
0.0300
-0.0050 (-14.29%)
At close: May 15, 2026
Market Cap2.03M -77.9%
Revenue (ttm)n/a
Net Income-4.13M
EPS-0.07
Shares Out67.69M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume24,707
Average Volume177,931
Open0.0300
Previous Close0.0350
Day's Range0.0300 - 0.0300
52-Week Range0.0150 - 0.3200
Beta0.00
RSI43.45
Earnings DateMay 15, 2026

About Cytophage Technologies

Cytophage Technologies Ltd., a biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada. It develops poultry health products under the AviPhage name; food safety products under the PhageFend name; bovine mastitis products under the BoviPhage name; and water-soluble solution for livestock producers under the FarmPhage name. The company is headquartered in Oak Bluff, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Steven Theriault
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol CYTO
Full Company Profile

Financial Performance

Financial Statements